Cargando…

Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium

STUDY QUESTION: What is the impact of administration of the selective progesterone receptor modulator (SPRM), ulipristal acetate (UPA) on the endometrium of women with fibroids? SUMMARY ANSWER: UPA administration altered expression of sex-steroid receptors and progesterone-regulated genes and was as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitaker, L.H.R., Murray, A.A., Matthews, R., Shaw, G., Williams, A.R.W., Saunders, P.T.K., Critchley, H.O.D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400066/ https://www.ncbi.nlm.nih.gov/pubmed/28130434 http://dx.doi.org/10.1093/humrep/dew359

Ejemplares similares

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies
por: Wagenfeld, Andrea, et al.
Publicado: (2016)

Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human Endometrium
por: Kolanska, Kamila, et al.
Publicado: (2021)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

SUN-019 The Selective Progesterone Receptor Modulator Ulipristal Acetate Blocks Glucocorticoid Receptor Transactivation
por: Smalls, Benjamin, et al.
Publicado: (2019)

Therapy with Ulipristal Acetate in a Hypertensive Patient
por: Alcalde Dominguez, A., et al.
Publicado: (2018)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2020)

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Asoprisnil, a Selective Progesterone Receptor Modulator (SPRM), Inhibits Melanosome Export in B16F10 Cells and HEMn-DP Melanocytes
por: Goenka, Shilpi, et al.
Publicado: (2020)

Emergency contraception: potential role of ulipristal acetate
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2010)

Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells
por: Shortrede, Jorge E., et al.
Publicado: (2018)

Risk–efficacy balance of ulipristal acetate compared to surgical alternatives
por: Middelkoop, Mei‐An, et al.
Publicado: (2021)

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Symptom relief of leiomyomatosis peritonealis disseminata with ulipristal acetate
por: Verguts, Jasper, et al.
Publicado: (2013)

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2
por: Gibson, D.A., et al.
Publicado: (2015)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas
por: de la Fuente, Elena, et al.
Publicado: (2016)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl(2)-L(1) Expression
por: Esber, Nathalie, et al.
Publicado: (2015)

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial
por: Whitaker, Lucy H.R., et al.
Publicado: (2023)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review
por: Rosato, Elena, et al.
Publicado: (2016)

Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix
por: Shin, So-Jin, et al.
Publicado: (2018)

The Use of Ulipristal Acetate (Esmya) Prior to Laparoscopic Myomectomy: Help or Hindrance?
por: Mallick, Rebecca, et al.
Publicado: (2019)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems
por: Wang, Peng, et al.
Publicado: (2022)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
por: Santoro, Angela, et al.
Publicado: (2018)

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism
por: von Wunster, S., et al.
Publicado: (2020)

Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids
por: Morgante, Giuseppe, et al.
Publicado: (2020)

Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
por: Kanda, Ranka, et al.
Publicado: (2021)

An additive interaction between the NFκB and estrogen receptor signalling pathways in human endometrial epithelial cells
por: King, A.E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dm4lcecpjhagdumgu8tvapdiq8